Evaluation of the calcium mobilizing action of acetaminophen and bromobenzene in rat hepatocyte cultures

Acetaminophen (APAP) and bromobenzene (BrB) are reported to selectively inhibit plasma membrane (PM) but not endoplasmic reticulum (ER) Ca²⁺ transport in rat liver (1). The ability of these hepatotoxicants to increase cytoplasmic Ca²⁺ levels as a result of disrupted Ca²⁺ pumping was determined in cultured rat hepatocytes by monitoring the activity of glycogen phosphorylase a, a Ca²⁺ -sensitive (via phosphorylase kinase) enzyme. Following exposure to 2.5 to 10 mM APAP for five minutes, dose-dependent increases in phosphorylase a activity were observed (58 to 190 U/g protein). Endoplasmic reticulum Ca²⁺ pump activity was not inhibited after any dose of APAP (56 nmol Ca²⁺ per milligram protein per 30 minutes). Phosphorylase a activity remained elevated for 60 minutes after exposure to APAP (124 μl/g protein). Following exposure to 0.5 to 2 mM BrB for five minutes, phosphorylase a activity also increased (58 to 229 U/g protein) in a dose-related manner. Endoplasmic reticulum Ca²⁺ pump activity was inhibited after BrB exposure (from 58 to 16 nmol Ca²⁺ per milligram protein per 30 minutes). Phosphorylase a activity remained elevated for 60 minutes after exposure to BrB (147 U/g protein). Evidence of elevated cytoplasmic Ca²⁺ is consistent with the inhibition of Ca²⁺ -extruding/sequestering mechanisms at hepatocyte PM and/or ER. Prolonged elevation of cytosolic Ca²⁺ levels could overstimulate Ca²⁺ -sensitive processes within liver cells and thus initiate or contribute to hepatotoxic injury.